Suppr超能文献

利用SYFPEITHI结合多项式方法预测肝癌特异性HLA - A2限制性CTL表位

Prediction of HLA-A2-restricted CTL epitope specific to HCC by SYFPEITHI combined with polynomial method.

作者信息

Dong Hai-Long, Sui Yan-Fang

机构信息

Department of Pathology, Fourth Military Medical University, Xi'an 710032, Shaanxi Province, China.

出版信息

World J Gastroenterol. 2005 Jan 14;11(2):208-11. doi: 10.3748/wjg.v11.i2.208.

Abstract

AIM

To predict the HLA-A2-restricted CTL epitopes of tumor antigens associated with hepatocellular carcinoma (HCC).

METHODS

MAGE-1, MAGE-3, MAGE-8, P53 and AFP were selected as objective antigens in this study for the close association with HCC. The HLA-A*0201 restricted CTL epitopes of objective tumor antigens were predicted by SYFPEITHI prediction method combined with the polynomial quantitative motifs method. The threshold of polynomial scores was set to -24.

RESULTS

The SYFPEITHI prediction values of all possible nonamers of a given protein sequence were added together and the ten high-scoring peptides of each protein were chosen for further analysis in primary prediction. Thirty-five candidates of CTL epitopes (nonamers) derived from the primary prediction results were selected by analyzing with the polynomial method and compared with reported CTL epitopes.

CONCLUSION

The combination of SYFPEITHI prediction method and polynomial method can improve the prediction efficiency and accuracy. These nonamers may be useful in the design of therapeutic peptide vaccine for HCC and as immunotherapeutic strategies against HCC after identified by immunology experiment.

摘要

目的

预测与肝细胞癌(HCC)相关的肿瘤抗原的HLA - A2限制性CTL表位。

方法

本研究选择MAGE - 1、MAGE - 3、MAGE - 8、P53和AFP作为与HCC密切相关的目标抗原。采用SYFPEITHI预测方法结合多项式定量基序方法预测目标肿瘤抗原的HLA - A*0201限制性CTL表位。多项式得分阈值设定为 - 24。

结果

将给定蛋白质序列的所有可能九聚体的SYFPEITHI预测值相加,在初步预测中选择每种蛋白质得分最高的十个肽段进行进一步分析。通过多项式方法分析从初步预测结果中筛选出35个CTL表位(九聚体)候选序列,并与已报道的CTL表位进行比较。

结论

SYFPEITHI预测方法与多项式方法相结合可提高预测效率和准确性。这些九聚体在经免疫学实验鉴定后,可能有助于设计HCC治疗性肽疫苗以及作为针对HCC的免疫治疗策略。

相似文献

1
Prediction of HLA-A2-restricted CTL epitope specific to HCC by SYFPEITHI combined with polynomial method.
World J Gastroenterol. 2005 Jan 14;11(2):208-11. doi: 10.3748/wjg.v11.i2.208.
3
Identification of HLA-A2-restricted CTL epitope encoded by the MAGE-n gene of human hepatocellular carcinoma.
Cancer Biol Ther. 2004 Sep;3(9):891-8. doi: 10.4161/cbt.3.9.1081. Epub 2004 Sep 15.
9
Prediction and preliminary screening of HLA-A*0201-restricted epitope peptides of human GPC3.
Int J Immunogenet. 2016 Jun;43(3):166-70. doi: 10.1111/iji.12260. Epub 2016 Apr 22.

引用本文的文献

2
Peptides of a Feather: How Computation Is Taking Peptide Therapeutics under Its Wing.
Genes (Basel). 2023 May 29;14(6):1194. doi: 10.3390/genes14061194.

本文引用的文献

2
Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review.
Hepatology. 2002 Nov;36(5 Suppl 1):S84-92. doi: 10.1053/jhep.2002.36817.
3
Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells.
J Gastroenterol Hepatol. 2002 Aug;17(8):889-96. doi: 10.1046/j.1440-1746.2002.02817.x.
4
Immunotherapy of hepatocellular carcinoma.
Expert Opin Biol Ther. 2002 Feb;2(2):123-33. doi: 10.1517/14712598.2.2.123.
8
A listing of human tumor antigens recognized by T cells.
Cancer Immunol Immunother. 2001 Mar;50(1):3-15. doi: 10.1007/s002620000169.
9
T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.
J Immunol. 2001 Apr 15;166(8):5300-8. doi: 10.4049/jimmunol.166.8.5300.
10
Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach.
Eur J Immunol. 2000 Aug;30(8):2216-25. doi: 10.1002/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0.CO;2-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验